The director of the Department of Pharmacy, Medicines, and Diagnostics (DPMED) wishes to adopt suitable software to strengthen the registration system for medicines and other health products. Although computerization yields improvements in the management of regulatory information, its effectiveness will largely depend on the presence of adequate medicines registration procedures and the system’s overall compliance with regional and international standards. This rapid evaluation thus seeks to analyze and understand Benin’s regulatory information management system for medicines registration, make appropriate recommendations, and propose an action plan based on emerging outcomes.
Archive | BeninRSS feed for this section
Deployment of the HIV and AIDS Commodity Management Tool OSPSIDA in Six Focus Countries in West and Central Africa: Benin, Burkina Faso, Cameroon, Guinea, Niger, and Togo
The availability and quality of HIV commodity, including antiretrovirals and HIV test kits, increases the demand for HIV care services and enables the scale-up of antiretroviral therapy. In West Africa and Central Africa, stock-outs often occurred because of poor coordination and information sharing among partners and lack of a reliable early warning system.
With funding from USAID West Africa and in collaboration with West African Health Organization and key stakeholders involved in the procurement and supply management at country and regional levels, SIAPS has provided supports to six countries in West and Central Africa: Benin, Burkina Faso, Cameroon, Guinea, Niger, and Togo. These countries will set up a web-based early warning system known as the HIV and AIDS Commodity Management Tool (OSPSIDA) to monitor HIV and AIDS commodities.
Transition of the HIV and AIDS Commodity Management Tool (OSPSIDA) to the West African Health Organization and Cameroon: Lessons Learned and Recommendations
USAID’s West African office asked SIAPS to provide support to six countries in the West and Central African region—Burkina Faso, Benin, Cameroon, Guinea, Niger, and Togo—to establish a web-based regional dashboard (OSPSIDA.org) that will create an early warning system (EWS) to monitor HIV and AIDS commodities and to detect and minimize the risk of stock-out in the focus countries.
In pursuit of this objective, and to ensure local ownership and long-term sustainability, the West African Health Organization (WAHO) has been involved since the project’s inception and has provided useful input during the design phase and official launch in Accra in April 2014. However, for the long-term sustainability of the dashboard and in an effort to support WAHO’s strategy of setting up security stock for West African countries, it is necessary to transfer the dashboard to WAHO’s Essential Medicines and Vaccines Program as its final home.
A strong pharmaceutical management system is critical for responding to and preventing public health emergencies. The US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, implemented by Management Sciences for Health (MSH), is helping four countries affected by Ebola—Sierra Leone, Guinea, Mali, and Benin—recover and rebuild essential drug management and delivery services and to increase their capacity and sustainability. The two-year project began in 2015.
Shretta R, Johnson B, Smith L, Doumbia S, de Savigny D, Anupindi R, Yadav P. Costing the supply chain for delivery of ACT and RDTs in the public sector in Benin and Kenya. Malaria Journal. 2015; 14:57.
This report estimates the cost of the Kenyan and Beninese distribution networks for artemisininbased combination therapies (ACTs) and rapid diagnostic tests (RDTs) in the public sector. Based on this work, we created an extrapolative model to allow donors and country budget planners to quickly and effectively estimate distribution costs for country roadmaps. This model is presented in a separate document.
This report achieved four objectives: (1) allow accurate costing for the delivery of malaria commodities to the end user, (2) allow accurate planning and budgeting, (3) provide realistic estimates of distribution costs for inclusion in roadmaps and proposals, and (4) inform policy discussion by improving the accuracy of costing for ACT and RDT supply chains.
The primary goal of the SIAPS TB Core portfolio was to ensure the availability of quality pharmaceutical products and support […]
- Rapport de quantification des produits de la santé reproductive, maternelle, néonatale et infantile pour la période de janvier 2017 à décembre 2020
La présente activité avait pour objectif d’apporter un soutien au Ministère de la Santé et de l’Hygiène publique (MSHP) pour […]
Project dates: September 2012 – December 2016